SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001401914-20-000068
Filing Date
2020-05-14
Accepted
2020-05-14 16:05:23
Documents
59
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dare_10qx2020x0331.htm 10-Q 716492
2 EXHIBIT 10.13B ex1013b.htm EX-10.13B 16890
3 EXHIBIT 10.14B ex1014b.htm EX-10.14B 16879
4 EXHIBIT 31.1 exhibit311_20200331.htm EX-31.1 18334
5 EXHIBIT 31.2 exhibit312_20200331.htm EX-31.2 17663
6 EXHIBIT 32.1 exhibit321_20200331.htm EX-32.1 4950
7 EXHIBIT 32.2 exhibit322_20200331.htm EX-32.2 5037
14 darebioinlinefullcolorrgba05.jpg GRAPHIC 130914
  Complete submission text file 0001401914-20-000068.txt   3925476

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT dare-20200331.xml EX-101.INS 527471
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20200331.xsd EX-101.SCH 43411
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dare-20200331_cal.xml EX-101.CAL 45245
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dare-20200331_def.xml EX-101.DEF 190954
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20200331_lab.xml EX-101.LAB 502404
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20200331_pre.xml EX-101.PRE 284031
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 20877712
SIC: 2834 Pharmaceutical Preparations